Is Medical Cannabis Mentioned in OCD Treatment Guidelines?

PostedFebruary 27, 2026

UpdatedFebruary 27, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Understanding whether cannabis guidelines for OCD are included in official recommendations helps patients and clinicians make informed decisions about alternative therapies.

Overview of OCD Clinical Guidance

Most cannabis guidelines for OCD focus on established therapies like cognitive behavioural therapy (CBT) and SSRIs. Research on medical cannabis is emerging, but inclusion in formal guidelines remains limited.

Recommendations from Medical Authorities

Current medical marijuana recommendations for OCD are cautious, often suggesting cannabis as a complementary option only in treatment-resistant cases or under clinical supervision.

Comparing to Official OCD Treatments

Official OCD treatments prioritise evidence-based interventions. Cannabis guidelines for OCD are not standard, highlighting the need for more robust clinical trials to validate efficacy and safety.

Clinical Practice Guidance

Clinicians may consider patient history, comorbidities, and prior responses when discussing clinical practice guidance for incorporating medical cannabis into care plans.

Future Directions

As research evolves, formal cannabis guidelines for OCD may expand to include dosage recommendations, cannabinoid selection, and monitoring protocols, ensuring safer integration into OCD management strategies.

Awareness of cannabis guidelines for OCD and current medical marijuana recommendations for OCD helps patients understand potential risks and benefits while complementing conventional treatments.

If you’re exploring cannabis treatment options for obsessive-compulsive disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obsessive-Compulsive Disorder.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.